Global Stents amp Related Implants Market Size By Type (Coronary Stents, Peripheral Stents), By Application (Hospitals, Ambulatory Settings), By Region, And Segment Forecasts, 2023 to 2032

The Global Stents & Related Implants Market was valued at USD 15.6 billion in 2023 and is projected to surpass USD 28.4 billion by 2031, growing at a CAGR of 7.8% during the forecast period from 2023 to 2031. The market is being driven by the rising prevalence of cardiovascular diseases, increasing demand for minimally invasive surgeries, and advancements in implantable device technology. With growing geriatric populations worldwide and lifestyle-induced health disorders on the rise, the use of stents and other related implants for vascular, orthopedic, and neurological conditions is increasing steadily.

Drivers:

Rising Incidence of Cardiovascular and Chronic Diseases

Cardiovascular diseases (CVDs), peripheral artery disease (PAD), and chronic conditions such as diabetes significantly increase the need for stents and vascular implants. These devices play a critical role in restoring blood flow, reducing the risk of heart attacks, and improving patient outcomes.

Increasing Preference for Minimally Invasive Procedures

Patients and healthcare providers are increasingly leaning towards minimally invasive techniques due to quicker recovery times, reduced surgical risks, and shorter hospital stays. This has spurred demand for advanced, drug-eluting, and bioresorbable stents.

Technological Advancements in Implant Design

Recent innovations, such as bioresorbable stents, next-gen drug coatings, and customizable 3D-printed implants, are revolutionizing the market. These devices offer improved biocompatibility, targeted delivery, and structural support while reducing long-term complications.

Restraints:

High Cost and Limited Reimbursement

Advanced stents and implants come with a high price tag, often leading to affordability issues in developing economies. Coupled with inconsistent reimbursement policies, this hinders widespread adoption.

Stringent Regulatory Approvals

Getting market approval for implantable medical devices involves complex and lengthy regulatory pathways, especially in Europe and North America. This delays market entry for novel products.

Opportunity:

Expanding Healthcare Access in Emerging Markets

Rapid improvements in healthcare infrastructure across Asia-Pacific, Latin America, and the Middle East are unlocking new growth avenues. Governments and private sectors are investing in advanced surgical facilities and devices, enhancing market penetration.

Next-Gen Biodegradable and Smart Implants

R&D in biodegradable and sensor-enabled implants opens up high-value opportunities. These devices allow real-time monitoring, reduce the need for secondary surgeries, and align with future trends in digital health and personalized medicine.

Market by System Type Insights:

Among system types, Coronary Stents held the largest market share in 2023 due to the high global burden of coronary artery disease. Drug-eluting stents (DES) dominated this category, attributed to their efficacy in reducing restenosis rates. Meanwhile, Peripheral Stents are gaining traction, particularly with rising PAD diagnoses in diabetic and elderly populations. Orthopedic and neurovascular implants are expected to witness accelerated growth during the forecast period due to broader applications and ongoing innovations.

Market by End-use Insights:

Hospitals and Cardiac Centers were the leading end-use segment in 2023, driven by high patient volumes, specialized surgical expertise, and access to state-of-the-art infrastructure. Ambulatory Surgical Centers (ASCs) are poised for rapid growth due to their cost-effectiveness, patient convenience, and increasing adoption of outpatient cardiac interventions. Specialty Clinics are also contributing significantly to market expansion, particularly in urban settings.

Market by Regional Insights:

North America dominated the market in 2023, supported by robust healthcare systems, high adoption of advanced medical devices, and strong reimbursement frameworks. Asia-Pacific is forecasted to be the fastest-growing region due to a surge in lifestyle-related diseases, aging populations, and expanding access to healthcare in countries like China, India, and Japan. Europe remains a key market, driven by public health initiatives and medical technology advancements.

Competitive Scenario:

Leading players in the Global Stents & Related Implants Market include Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Cook Medical, Biotronik SE & Co. KG, MicroPort Scientific Corporation, Cardinal Health Inc., and Stryker Corporation. These companies are investing in R&D, strategic mergers and acquisitions, and global expansion to consolidate their market positions.

Key Market Developments:

In 2023, Abbott launched a new-generation drug-eluting coronary stent in Europe, engineered for improved flexibility and reduced restenosis.

Boston Scientific expanded its peripheral interventions portfolio in 2024 through acquisition of a vascular access device firm.

In 2025, Medtronic received FDA clearance for its biodegradable coronary stent system, targeting long-term safety and efficacy.

Scope of Work – Global Stents & Related Implants Market

Report Metric Details

Market Size (2023) USD 15.6 billion

Projected Market Size (2031) USD 28.4 billion

CAGR (2023–2031) 7.8%

Market Segments System Type (Coronary, Peripheral, Neurovascular, Orthopedic), End-use (Hospitals, ASCs, Clinics), Region

Growth Drivers Cardiovascular disease prev